Drug recall
Menomune - A/C/Y/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combinbed, single-dose…
FDA recall event 25061 · Class III · Aventis Pasteur Inc,
Key facts
| Event ID | 25061 |
|---|---|
| Recall numbers | B-1043-3 |
| Recalling firm | Aventis Pasteur Inc, |
| Product type | Biologics |
| Products | Menomune - A/C/Y/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combinbed, single-dose vials (including single-dose in five dose packaging) (4lots). |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Product failed to meet potency specification during stability testing at twelve months. |
| Initiation date | Sep 12, 2002 |
| City | Swiftwater |
| Country | United States |
| FEI number | 2518760 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports